Abstract:Background & Aims: <AbstractText Label="Background & Aims" NlmCategory="UNASSIGNED">XBP1 modulates the macrophage proinflammatory response, but its function in macrophage stimulator of interferon genes (STING) activation and liver fibrosis is unknown. X-box binding protein 1 (XBP1) has been shown to promote macrophage nucleotide-binding oligomerization domain, leucine-rich repeat and pyrin domain-containing 3 (NLRP3) activation in steatohepatitis. Herein, we aimed to explore the underlying mechanism of XBP1 in the regulation of STING signalling and the subsequent NLRP3 activation during liver fibrosis.</AbstractText>Methods: <AbstractText Label="Methods" NlmCategory="UNASSIGNED">XBP1 expression was measured in the human fibrotic liver tissue samples. Liver fibrosis was induced in myeloid-specific Xbp1-, STING-, and Nlrp3-deficient mice by carbon tetrachloride injection, bile duct ligation, or a methionine/choline-deficient diet.</AbstractText>Results: <AbstractText Label="Results" NlmCategory="UNASSIGNED">Although increased XBP1 expression was observed in the fibrotic liver macrophages of mice and clinical patients, myeloid-specific Xbp1 deficiency or pharmacological inhibition of XBP1 protected the liver against fibrosis. Furthermore, it inhibited macrophage NLPR3 activation in a STING/IRF3-dependent manner. Oxidative mitochondrial injury facilitated cytosolic leakage of macrophage self-mtDNA and cGAS/STING/NLRP3 signalling activation to promote liver fibrosis. Mechanistically, RNA sequencing analysis indicated a decreased mtDNA expression and an increased BCL2/adenovirus E1B interacting protein 3 (BNIP3)-mediated mitophagy activation in Xbp1-deficient macrophages. Chromatin immunoprecipitation (ChIP) assays further suggested that spliced XBP1 bound directly to the Bnip3 promoter and inhibited the transcription of Bnip3 in macrophages. Xbp1 deficiency decreased the mtDNA cytosolic release and STING/NLRP3 activation by promoting BNIP3-mediated mitophagy activation in macrophages, which was abrogated by Bnip3 knockdown. Moreover, macrophage XBP1/STING signalling contributed to the activation of hepatic stellate cells.</AbstractText>Conclusions: <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">Our findings demonstrate that XBP1 controls macrophage cGAS/STING/NLRP3 activation by regulating macrophage self-mtDNA cytosolic leakage via BNIP3-mediated mitophagy modulation, thus providing a novel target against liver fibrosis.</AbstractText>Lay summary: <AbstractText Label="Lay summary" NlmCategory="UNASSIGNED">Liver fibrosis is a typical progressive process of chronic liver disease, driven by inflammatory and immune responses, and is characterised by an excess of extracellular matrix in the liver. Currently, there is no effective therapeutic strategy for the treatment of liver fibrosis, resulting in high mortality worldwide. In this study, we found that myeloid-specific Xbp1 deficiency protected the liver against fibrosis in mice, while XBP1 inhibition ameliorated liver fibrosis in mice. This study concluded that targeting XBP1 signalling in macrophages may provide a novel strategy for protecting the liver against fibrosis.</AbstractText>

Myeloid-specific disruption of recombination signal binding protein Jκ ameliorates hepatic fibrosis by attenuating inflammation through cylindromatosis in mice.

Blocking Notch signal in myeloid cells alleviates hepatic ischemia reperfusion injury by repressing the activation of NF-κB through CYLD

Myeloid-specific Blockade of Notch Signaling Ameliorates Nonalcoholic Fatty Liver Disease in Mice

Disruption of Myofibroblastic Notch Signaling Attenuates Liver Fibrosis by Modulating Fibrosis Progression and Regression.

Myeloid-specific Targeting of Notch Ameliorates Murine Renal Fibrosis Via Reduced Infiltration and Activation of Bone Marrow-Derived Macrophage

Myeloid Fbxw7 Prevents Pulmonary Fibrosis by Suppressing TGF-beta Production

Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice

Myeloid Notch1 deficiency activates the RhoA/ROCK pathway and aggravates hepatocellular damage in mouse ischemic livers

Targeting Notch1-YAP Circuit Reprograms Macrophage Polarization and Alleviates Acute Liver Injury in Mice

MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization

XBP1-mediated activation of the STING signalling pathway in macrophages contributes to liver fibrosis progression

Macrophage Notch1 Inhibits TAK1 Function and RIPK3-mediated Hepatocyte Necroptosis Through Activation of Β-Catenin Signaling in Liver Ischemia and Reperfusion Injury

The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis

KLF4 in Macrophages Attenuates TNFα-Mediated Kidney Injury and Fibrosis

Exosome-mediated delivery of RBP-J decoy oligodeoxynucleotides ameliorates hepatic fibrosis in mice

MyD88 in Macrophages Enhances Liver Fibrosis by Activation of NLRP3 Inflammasome in HSCs

Activating SIRT1 deacetylates NF-κB p65 to alleviate liver inflammation and fibrosis via inhibiting NLRP3 pathway in macrophages

Notch-mediated hepatocyte MCP-1 secretion causes liver fibrosis

Functional interaction between macrophages and hepatocytes dictate the outcome of liver fibrosis

Macrophage-specific MyD88 Deletion and Pharmacological Inhibition Prevents Liver Damage in Non-Alcoholic Fatty Liver Disease Via Reducing Inflammatory Response

Disruption of the transcription factor recombination signal-binding protein-Jkappa (RBP-J) leads to veno-occlusive disease and interfered liver regeneration in mice.